Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Aide

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory diseaseNicolas Aide, Laurent Poulain, Mélanie Briand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patientsElske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 3, 2021
New PET technologies - embracing progress and pushing the limitsNicolas Aide, Charline Lasnon, Adam Kesner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 22, 2020
Predicting tumor response and outcome of second-look surgery with <sup>18</sup>F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancerNicolas Aide, Pauline Fauchille, Elodie Coquan, et al.
Leukemia & Lymphoma|December 16, 2006
Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative studyChristophe Fruchart, Oumedaly Reman, Nolwenn Le Stang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2017
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 studyElske Quak, David Blanchard, Benjamin Houdu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2017
Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvementHubert de Boysson, Anael Dumont, Eric Liozon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2016
Does PET SUV Harmonization Affect PERCIST Response Classification?Elske Quak, Pierre-Yves Le Roux, Charline Lasnon, et al.
EJNMMI Physics|June 1, 2017
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization programCharline Lasnon, Elske Quak, Pierre-Yves Le Roux, et al.
Seminars in Nuclear Medicine|February 18, 2025
Artificial Intelligence for Drug Discovery: An Update and Future ProspectsHarrison J Howell, Jeremy P McGale, Aurélie Choucair, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
Early evaluation of the effects of chemotherapy with longitudinal FDG small-animal PET in human testicular cancer xenografts: early flare response does not reflect refractory diseaseNicolas Aide, Laurent Poulain, Mélanie Briand, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patientsElske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 3, 2021
New PET technologies - embracing progress and pushing the limitsNicolas Aide, Charline Lasnon, Adam Kesner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 22, 2020
Predicting tumor response and outcome of second-look surgery with <sup>18</sup>F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancerNicolas Aide, Pauline Fauchille, Elodie Coquan, et al.
Leukemia & Lymphoma|December 16, 2006
Prognostic value of early 18 fluorodeoxyglucose positron emission tomography and gallium-67 scintigraphy in aggressive lymphoma: a prospective comparative studyChristophe Fruchart, Oumedaly Reman, Nolwenn Le Stang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2017
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 studyElske Quak, David Blanchard, Benjamin Houdu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 25, 2017
Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvementHubert de Boysson, Anael Dumont, Eric Liozon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2016
Does PET SUV Harmonization Affect PERCIST Response Classification?Elske Quak, Pierre-Yves Le Roux, Charline Lasnon, et al.
EJNMMI Physics|June 1, 2017
EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization programCharline Lasnon, Elske Quak, Pierre-Yves Le Roux, et al.
Seminars in Nuclear Medicine|February 18, 2025
Artificial Intelligence for Drug Discovery: An Update and Future ProspectsHarrison J Howell, Jeremy P McGale, Aurélie Choucair, et al.
Pageof 12